Parjanya Kumar Shukla

Quinazoline clubbed 1,3,5-triazine derivatives as VEGFR2 kinase inhibitors: design, synthesis, docking, in vitro cytotoxicity and in ovo antiangiogenic activity

Prateek Pathak, Parjanya Kumar Shukla, Vikas Kumar et al. · Inflammopharmacology · 2018 · 31 citations

Vegfr2 Kinase Inhibitors, Medicinal Chemistry, Medicine +10

Quinazoline based 1,3,5‐triazine derivatives as cancer inhibitors by impeding the phosphorylated RET tyrosine kinase pathway: Design, synthesis, docking, and QSAR study

Prateek Pathak, Vladislav Naumovich, Maria Grishina et al. · Archiv der Pharmazie · 2019 · 27 citations

Molecular Docking, Medicinal Chemistry, Cancer Inhibitors +15

1, 2, 4-Triazole Scafolds : Recent Advances and Pharmacological Applications

Anjali Thakur, Puspraj S. Gupta, Parjanya Kumar Shukla et al. · International Journal of Current Research and Academic Review · 2016 · 19 citations · Full text

Combinatorial Chemistry, Molecular Pharmacology, Medicinal Chemistry +14

1,2,4‐Triazole‐conjugated 1,3,4‐thiadiazole hybrid scaffolds: A potent ameliorant of carrageenan‐induced inflammation by lessening proinflammatory mediators

Prateek Pathak, Parjanya Kumar Shukla, Vladislav Naumovich et al. · Archiv der Pharmazie · 2019 · 16 citations

Silica catalyzed one pot synthesis of hybrid thiazolidin-4-one derivatives as anti-tubercular and anti-inflammatory agent by attenuating COX-2 pathway

Prateek Pathak, Parjanya Kumar Shukla, Vladislav Naumovich et al. · Synthetic Communications · 2019 · 14 citations

Bioorganic Chemistry, Pharmaceutical Chemistry, Drug Resistance +16